Trials / Completed
CompletedNCT05414318
CTAG Dissection/Trauma Post Marketing Surveillance Japan
Post Marketing Surveillance of the Conformable GORE® TAG® Thoracic Endoprosthesis (CTAG)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 55 (actual)
- Sponsor
- W.L.Gore & Associates · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Post Marketing Surveillance of the Conformable GORE® TAG® Thoracic Endoprosthesis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Conformable GORE® TAG® Thoracic Endoprosthesis | Thoracic Endoprosthesis |
Timeline
- Start date
- 2016-01-05
- Primary completion
- 2022-12-23
- Completion
- 2022-12-23
- First posted
- 2022-06-10
- Last updated
- 2024-10-03
- Results posted
- 2024-10-03
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05414318. Inclusion in this directory is not an endorsement.